WO2008047655A1 - Urea derivative for use in quantification of hydrogen peroxide - Google Patents

Urea derivative for use in quantification of hydrogen peroxide Download PDF

Info

Publication number
WO2008047655A1
WO2008047655A1 PCT/JP2007/069799 JP2007069799W WO2008047655A1 WO 2008047655 A1 WO2008047655 A1 WO 2008047655A1 JP 2007069799 W JP2007069799 W JP 2007069799W WO 2008047655 A1 WO2008047655 A1 WO 2008047655A1
Authority
WO
WIPO (PCT)
Prior art keywords
formula
hydrogen peroxide
urea derivative
group
present
Prior art date
Application number
PCT/JP2007/069799
Other languages
French (fr)
Japanese (ja)
Inventor
Katsuya Noguchi
Eiji Watanabe
Munetaka Ishiyama
Original Assignee
Dojindo Laboratories
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Dojindo Laboratories filed Critical Dojindo Laboratories
Publication of WO2008047655A1 publication Critical patent/WO2008047655A1/en

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12QMEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/26Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving oxidoreductase
    • C12Q1/28Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving oxidoreductase involving peroxidase
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C309/00Sulfonic acids; Halides, esters, or anhydrides thereof
    • C07C309/01Sulfonic acids
    • C07C309/02Sulfonic acids having sulfo groups bound to acyclic carbon atoms
    • C07C309/03Sulfonic acids having sulfo groups bound to acyclic carbon atoms of an acyclic saturated carbon skeleton
    • C07C309/13Sulfonic acids having sulfo groups bound to acyclic carbon atoms of an acyclic saturated carbon skeleton containing nitrogen atoms, not being part of nitro or nitroso groups, bound to the carbon skeleton
    • C07C309/14Sulfonic acids having sulfo groups bound to acyclic carbon atoms of an acyclic saturated carbon skeleton containing nitrogen atoms, not being part of nitro or nitroso groups, bound to the carbon skeleton containing amino groups bound to the carbon skeleton
    • C07C309/15Sulfonic acids having sulfo groups bound to acyclic carbon atoms of an acyclic saturated carbon skeleton containing nitrogen atoms, not being part of nitro or nitroso groups, bound to the carbon skeleton containing amino groups bound to the carbon skeleton the nitrogen atom of at least one of the amino groups being part of any of the groups, X being a hetero atom, Y being any atom
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D279/00Heterocyclic compounds containing six-membered rings having one nitrogen atom and one sulfur atom as the only ring hetero atoms
    • C07D279/101,4-Thiazines; Hydrogenated 1,4-thiazines
    • C07D279/141,4-Thiazines; Hydrogenated 1,4-thiazines condensed with carbocyclic rings or ring systems
    • C07D279/18[b, e]-condensed with two six-membered rings
    • C07D279/22[b, e]-condensed with two six-membered rings with carbon atoms directly attached to the ring nitrogen atom
    • C07D279/30[b, e]-condensed with two six-membered rings with carbon atoms directly attached to the ring nitrogen atom with acyl radicals attached to the ring nitrogen atom

Definitions

  • the present invention relates to a novel compound having a urea derivative structure, and is particularly suitable for use as a color reagent for quantifying hydrogen peroxide in the presence of peroxidase in clinical tests. It relates to new compounds.
  • a representative example of a color reagent for quantifying hydrogen peroxide in the presence of peroxidase is a compound having a urea derivative structure.
  • Patent Document 1 discloses a compound having a structure in which two substituted phenyl groups are bonded to urea.
  • Patent Document 2 proposes a compound having a urea derivative structure that has improved properties such as solubility in water compared to the compound described in Patent Document 1 above. Has been.
  • the compound described in Patent Document 2 has improved water solubility compared to the compound of Patent Document 1. It is still insufficient for use in clinical tests, and is not stable in aqueous solution. The problem remains.
  • Patent Document 1 Japanese Patent Publication No. 60-33479
  • Patent Document 2 Japanese Patent Publication No. 7-121901
  • the purpose of the present invention is to achieve solubility and stability in aqueous solutions corresponding to biological fluid samples. It is to provide a new substance that is excellent in use and suitable for use as a clinical reagent for the determination of hydrogen peroxide in the presence of peroxidase.
  • the present invention is a color reagent that comprises a urea derivative represented by the following general formula (I) and the urea derivative and is used for the determination of hydrogen peroxide in the presence of peroxidase.
  • R 1 represents an atomic group represented by the following general formula (R), and R 2 and R 3 each independently represents a 4-disubstituted aminoaryl group.
  • the aryl groups of R 2 and R 3 may be bonded to each other via a sulfur atom or an oxygen atom, and at least one of the aryl groups of R 2 and R 3 is an S sulfonic acid group. It ’s replaced!
  • n represents an integer of 1 to 4
  • X represents a hydrogen atom, sodium atom or potassium atom.
  • the compound of the present invention (urea derivative) has very high solubility in water, and also has very good stability in an aqueous solution. Therefore, the compounds of the present invention are used in clinical tests at high concentrations for the determination of hydrogen peroxide in the presence of peroxidase. It is particularly useful as a color reagent.
  • FIG. 1 shows a reaction scheme for synthesizing an example of a compound of the present invention (urea derivative).
  • FIG. 2A shows a calibration curve when hydrogen peroxide is quantified in the presence of peroxidase using the compound of the present invention and a comparative compound.
  • FIG. 2B shows a calibration curve when hydrogen peroxide is quantified in the presence of peroxidase using the compound of the present invention and a comparative compound.
  • FIG. 3A shows the stability in aqueous solutions measured for the compounds of the present invention and comparative compounds.
  • FIG. 3B shows the stability in aqueous solutions measured for the compounds of the present invention and comparative compounds.
  • Patent Document 2 discloses a compound represented by the following formulas (C 1) and (C 2), for example, as being extremely easily soluble in water.
  • the compound of the present invention (urea derivative) has a specific atomic group as R 1 of the formula (I), that is, an atomic group represented by the formula ( ⁇ ).
  • R 1 of the formula (I) an atomic group represented by the formula ( ⁇ ).
  • water solubility is higher than the compounds of the above formulas (C 1) and (C 2), and stability in aqueous solution is also good. Yes (see examples below).
  • n is a force that is an integer of;! To 4, preferably 2.
  • X represents a hydrogen atom, a sodium atom or a potassium atom, preferably a sodium atom.
  • R 2 and R 3 in formula (I) each independently represent a 4-disubstituted aminoaryl group, and the aryl groups of R 2 and R 3 are bonded to each other via a sulfur atom or an oxygen atom. Also good.
  • this embodiment which may be substituted with at least one S sulfonic acid group in the aryl group of R 2 and R 3 , includes the case where a sulfonic acid group is bonded to the substituted amino group.
  • a phenyl group is preferred as an aryl group.
  • the urea derivative of the present invention particularly preferred for constituting a color reagent represented by the formula (I) and used for the determination of hydrogen peroxide in the presence of peroxidase, the following formula ( Examples thereof include, but are not limited to, compounds represented by III) or (IV).
  • the urea derivative of the present invention represented by the formula (I) can be synthesized by the synthesis method found by the present inventors. That is, as illustrated in FIG. 1, a compound in which R 2 is CH C OONa in the formula (I) is used as a raw material (therefore, this raw material compound is a compound of the formula (C 1) or the formula (C 2). (This corresponds to the target compound of Patent Document 2), and this is reacted with an aminoalkanesulfonic acid such as taurine (2-aminoethanesulfonic acid) using a carpositimide such as dicyclohexylcarpositimide as a dehydrating condensing agent. (See examples below)
  • the compound of the present invention of the formula (III) was synthesized as follows. To 2.0 g of the compound of formula (C 1) was added 0.1N HCllOml and concentrated. 20ml THF to concentrate 3 ml of water and 3.27 g of dicyclohexyl carpositimide were added and stirred in an ice bath. After stirring for 30 minutes, 0.662 g of taurine and 0.444 g of sodium bicarbonate were dissolved in 3 ml of water and added to the reaction solution. -After stirring at room temperature, 2.18 g of dicyclohexyl carpositimide was further added. After 3 hours, stirring was stopped and the reaction solution was filtered and concentrated.
  • the compound of the present invention of the formula (IV) was synthesized as follows.
  • the compound l.Og of the formula (C2) was charged with 0.1N HCllOml and concentrated.
  • To the concentrate were added THFlOml, 3 ml of water and 2.16 g of dicyclohexyl carpositimide, and the mixture was stirred in an ice bath. After stirring for 30 minutes, 0.328 g of taurine and 0.213 g of sodium bicarbonate were dissolved in 3 ml of water and added to the reaction solution. After 3 hours, stirring was stopped and the reaction solution was filtered and concentrated.
  • the concentrate was purified by chromoform form and dried under reduced pressure to obtain 0.40 g of white powder.
  • the compounds (III) and (IV) of the present invention and the compounds (C 1) and (C 2) described in Patent Document 2 for comparison have a concentration of 0 ⁇ lmmol / U peroxidase at a concentration of 3.3 u / ml. Thus, it was dissolved in 50 mM MES [2 morpholinoethanesulfonic acid] sodium hydroxide buffer (pH 5.5).
  • the sample solution was added to 3 ml of the measurement solution 1.5, 3.0, 15 and 301 and heated at 37 ° C for 5 minutes, and then the absorbance at the maximum absorption wavelength was measured.
  • Figures 2A and 2B show the relationship between hydrogen peroxide concentration and absorbance. From FIG. 2A and FIG. 2B, the calibration curve of absorbance at the maximum absorption wavelength plotted against each hydrogen peroxide concentration M) showed quantitativeness.
  • the compounds (III) and (IV) of the present invention showed the same or better sensitivity than the comparative compounds (C 1) and (C 2).
  • the compounds (III) and (IV) of the present invention and the comparative compounds (C 1) and (C 2) were each dissolved in pure water at 25 ° C., and the solubility was determined.
  • Table 1 shows the solubilities of the compounds (III) and (IV) of the present invention and the comparative compounds (C 1) and (C 2).
  • the compounds (III) and (IV) of the present invention are more water-soluble than (C 1) and (C 2), respectively.
  • the compounds (III) and (IV) of the present invention and the comparative compounds (C 1) and (C 2) were each prepared with 50 mM MES sodium hydroxide buffer ( ⁇ 5 ⁇ 5) so as to be 10 mmol / l. Stored at 40 ° C, protected from light.
  • Figures 3A and 3B show the relationship between elapsed days and absorbance. As shown in FIGS. 3A and 3B, the compounds (III) and (IV) of the present invention have better stability than the comparative compounds (C 1) and (C 2).

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Zoology (AREA)
  • Wood Science & Technology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Health & Medical Sciences (AREA)
  • Immunology (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • Microbiology (AREA)
  • Molecular Biology (AREA)
  • Analytical Chemistry (AREA)
  • Physics & Mathematics (AREA)
  • Biotechnology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Engineering & Computer Science (AREA)
  • General Health & Medical Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Nitrogen- Or Sulfur-Containing Heterocyclic Ring Compounds With Rings Of Six Or More Members (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)

Abstract

Disclosed is a novel substance which has excellent solubility and stability in an aqueous solution corresponding to a biological liquid sample and can be suitably used as a clinical reagent for quantifying hydrogen peroxide in the presence of a peroxidase. Specifically disclosed is an urea derivative represented by the formula (I) [wherein R1 represents an atomic group represented by the formula (II); R2 and R3 independently represent a 4-disubstituted aminoaryl group, provided the aryl group in R2 and the aryl group in R3 may be linked to each other through a sulfur or oxygen atom, and at least one site in the aryl group in each of R2 and R3 may be substituted by a sulfonate group; n represents an integer of 1 to 4; and X represents a hydrogen, sodium or potassium atom].

Description

明 細 書  Specification
過酸化水素の定量に用いられる尿素誘導体  Urea derivatives used for the determination of hydrogen peroxide
技術分野  Technical field
[0001] 本発明は、尿素誘導体の構造を有する新規な化合物に関し、特に、臨床検査にお いてペルォキシダーゼの存在下に過酸化水素を定量するための呈色試薬等として 使用されるのに好適な新規化合物に関する。  The present invention relates to a novel compound having a urea derivative structure, and is particularly suitable for use as a color reagent for quantifying hydrogen peroxide in the presence of peroxidase in clinical tests. It relates to new compounds.
背景技術  Background art
[0002] 生体中では各種の酸化酵素の作用により基質が酸化され、その際に過酸化水素( H O )を生成する反応が幾つか認められる。ゥリカーゼによる尿酸の酸化、コレステ ローノレ'ォキシダーゼによるコレステロールの酸化などがその例である。したがって、 生成する過酸化水素を定量することにより基質の定量を行うことが臨床検査における 重要な手段となっており、この目的のために、ペルォキシダーゼの存在下に過酸化 水素と反応して呈色する化合物が臨床試薬として用いられている。  [0002] In the living body, several reactions are observed in which a substrate is oxidized by the action of various oxidases, and hydrogen peroxide (H 2 O 2) is generated at that time. Examples include uric acid oxidation by uricase and cholesterol oxidation by cholesterol oxidase. Therefore, quantification of the substrate by quantifying the amount of hydrogen peroxide produced is an important means in clinical tests, and for this purpose, it reacts with hydrogen peroxide in the presence of peroxidase to give color. These compounds are used as clinical reagents.
[0003] ペルォキシダーゼの存在下に過酸化水素を定量する呈色試薬としては、尿素誘導 体の構造を有する化合物が代表例として挙げられる。例えば、特公昭 60— 33479 号公報(特許文献 1)には、尿素に 2個の置換フエニル基が結合した構造の化合物が 開示されている。さらに、特公平 7— 121901号公報(特許文献 2)には、上記特許文 献 1に記載されている化合物よりも水に対する溶解度などの特性を向上させたとする 尿素誘導体の構造を有する化合物が提案されている。この特許文献 2に記載の化合 物は、特許文献 1の化合物に比べて水溶性は向上されている力 臨床検査に用いら れるには未だ十分でなぐさらに、水溶液中での安定性が良くないという問題も残さ れている。  [0003] A representative example of a color reagent for quantifying hydrogen peroxide in the presence of peroxidase is a compound having a urea derivative structure. For example, Japanese Patent Publication No. 60-33479 (Patent Document 1) discloses a compound having a structure in which two substituted phenyl groups are bonded to urea. Furthermore, Japanese Patent Publication No. 7-121901 (Patent Document 2) proposes a compound having a urea derivative structure that has improved properties such as solubility in water compared to the compound described in Patent Document 1 above. Has been. The compound described in Patent Document 2 has improved water solubility compared to the compound of Patent Document 1. It is still insufficient for use in clinical tests, and is not stable in aqueous solution. The problem remains.
特許文献 1:特公昭 60— 33479号公報  Patent Document 1: Japanese Patent Publication No. 60-33479
特許文献 2:特公平 7— 121901号公報  Patent Document 2: Japanese Patent Publication No. 7-121901
発明の開示  Disclosure of the invention
発明が解決しょうとする課題  Problems to be solved by the invention
[0004] 本発明の目的は、生体液試料に相応する水溶液中における溶解度および安定性 に優れ、ペルォキシダーゼの存在下に過酸化水素を定量する臨床試薬として用いら れるのに適した新しい物質を提供することにある。 [0004] The purpose of the present invention is to achieve solubility and stability in aqueous solutions corresponding to biological fluid samples. It is to provide a new substance that is excellent in use and suitable for use as a clinical reagent for the determination of hydrogen peroxide in the presence of peroxidase.
課題を解決するための手段  Means for solving the problem
[0005] 本発明者は、研究を重ねた結果、如上の目的を達成し得る化合物の合成に成功し 、本発明を導き出した。 [0005] As a result of repeated research, the present inventor succeeded in synthesizing a compound that can achieve the above-mentioned object, and derived the present invention.
すなわち、本発明は、下記の一般式 (I)で表される尿素誘導体、および該尿素誘導 体から成り、ペルォキシダーゼの存在下に過酸化水素の定量に用いられる呈色試薬 である。  That is, the present invention is a color reagent that comprises a urea derivative represented by the following general formula (I) and the urea derivative and is used for the determination of hydrogen peroxide in the presence of peroxidase.
[0006] [化 1] [0006] [Chemical 1]
Figure imgf000004_0001
Figure imgf000004_0001
R2- N- R3 R2- N- R 3
[0007] 式 (I)中、 R1は下記の一般式 (Π)で表される原子団を示し、 R2および R3は、それぞ れ独立して、 4ージ置換アミノアリール基を表わし、 R2と R3のァリール基は硫黄原子ま たは酸素原子を介して互いに結合してもよぐさらに、 R2と R3のァリール基の少なくと も 1ケ所カ Sスルホン酸基で置換されて!/、てもよレ、。 [0007] In formula (I), R 1 represents an atomic group represented by the following general formula (R), and R 2 and R 3 each independently represents a 4-disubstituted aminoaryl group. The aryl groups of R 2 and R 3 may be bonded to each other via a sulfur atom or an oxygen atom, and at least one of the aryl groups of R 2 and R 3 is an S sulfonic acid group. It ’s replaced!
[0008] [化 2]  [0008] [Chemical 2]
II H II H
~ C H2 C - N -(C H2)„- S OaX 式 (Π)中、 nは 1〜4の整数を表し、 Xは水素原子、ナトリウム原子またはカリウム原 子を表す。 ~ CH 2 C - N - ( CH 2) "- S OaX formula ([pi), n represents an integer of 1 to 4, X represents a hydrogen atom, sodium atom or potassium atom.
発明の効果  The invention's effect
[0009] 本発明の化合物(尿素誘導体)は、水に対する溶解度がきわめて大きぐまた、水 溶液中の安定性も非常に良好である。したがって、本発明の化合物は、臨床検査に おいてペルォキシダーゼの存在下に過酸化水素を定量するための高濃度で使用さ れる呈色試薬として特に有用である。 [0009] The compound of the present invention (urea derivative) has very high solubility in water, and also has very good stability in an aqueous solution. Therefore, the compounds of the present invention are used in clinical tests at high concentrations for the determination of hydrogen peroxide in the presence of peroxidase. It is particularly useful as a color reagent.
図面の簡単な説明  Brief Description of Drawings
[0010] [図 1]本発明の化合物 (尿素誘導体)の例を合成する反応スキームを示す。  FIG. 1 shows a reaction scheme for synthesizing an example of a compound of the present invention (urea derivative).
[図 2A]本発明の化合物および比較化合物を用いてペルォキシダーゼの存在下に過 酸化水素を定量する場合の検量線を示す。  FIG. 2A shows a calibration curve when hydrogen peroxide is quantified in the presence of peroxidase using the compound of the present invention and a comparative compound.
[図 2B]本発明の化合物および比較化合物を用いてペルォキシダーゼの存在下に過 酸化水素を定量する場合の検量線を示す。  FIG. 2B shows a calibration curve when hydrogen peroxide is quantified in the presence of peroxidase using the compound of the present invention and a comparative compound.
[図 3A]本発明の化合物および比較化合物について測定した水溶液中における安定 性を示す。  FIG. 3A shows the stability in aqueous solutions measured for the compounds of the present invention and comparative compounds.
[図 3B]本発明の化合物および比較化合物について測定した水溶液中における安定 性を示す。  FIG. 3B shows the stability in aqueous solutions measured for the compounds of the present invention and comparative compounds.
発明を実施するための最良の形態  BEST MODE FOR CARRYING OUT THE INVENTION
[0011] 既述の特許文献 2に記載されている過酸化水素定量用呈色試薬となる化合物は、 本発明の尿素誘導体を表す式 (I)において、 R1で表される原子団の末端にカルボキ シル基、ァリールスルホニル基又はスルホアリール基を存在させ、これにより水溶性 の向上を図ったものと考えられる。とりわけ、特許文献 2には、水に対する溶解性にお いて極めて易溶なものとして、例えば、下記の式(C 1)や(C 2)で表される化合 物が示されている。 [0011] The compound serving as the color reagent for quantifying hydrogen peroxide described in Patent Document 2 is the terminal of the atomic group represented by R 1 in the formula (I) representing the urea derivative of the present invention. It is considered that a carboxyl group, an arylsulfonyl group, or a sulfoaryl group was present in the water to improve the water solubility. In particular, Patent Document 2 discloses a compound represented by the following formulas (C 1) and (C 2), for example, as being extremely easily soluble in water.
[0012] [化 3]  [0012] [Chemical 3]
Figure imgf000005_0001
Figure imgf000005_0001
[0013] [化 4] [0013] [Chemical 4]
Figure imgf000006_0001
Figure imgf000006_0001
[0014] これらの化合物は、臨床検査に際してペルォキシダーゼの存在下に過酸化水素を 定量するために高濃度で用いられる呈色試薬としては、水に対する溶解度や水溶液 中での安定性においては充分に満足すべきものではなかった。 [0014] These compounds are sufficiently satisfactory in the solubility in water and the stability in aqueous solution as a color reagent used at high concentration to quantify hydrogen peroxide in the presence of peroxidase in clinical examinations. It shouldn't have been.
[0015] これに対して、本発明の化合物(尿素誘導体)は、式 (I)の R1として特定の原子団、 すなわち式 (Π)で表される原子団とすることにより、特許文献 1において特に水溶性 が優れてレ、ると記載されて!/、る上記の式 (C 1)や(C 2)の化合物よりも水溶性が 高ぐしかも、水溶液中での安定性も良好である(後述の実施例参照)。 On the other hand, the compound of the present invention (urea derivative) has a specific atomic group as R 1 of the formula (I), that is, an atomic group represented by the formula (Π). In particular, water solubility is higher than the compounds of the above formulas (C 1) and (C 2), and stability in aqueous solution is also good. Yes (see examples below).
[0016] 本発明の尿素誘導体を表す式(I)の R1となる式(Π)において、 nは;!〜 4の整数であ る力 好ましくは 2である。また、式 (Π)において Xは、水素原子、ナトリウム原子または カリウム原子を表す力 好ましくはナトリウム原子である。さらに、式 (I)の R2および R3 は、それぞれ独立して、 4ージ置換アミノアリール基を表わし、 R2と R3のァリール基は 硫黄原子または酸素原子を介して互いに結合してもよい。さらに、 R2と R3のァリール 基の少なくとも 1ケ所カ Sスルホン酸基で置換されていてもよぐこの態様には、置換アミ ノ基にスルホン酸基が結合されている場合も含まれる。ここで、ァリール基として好ま しいのはフエニル基である。力、くして、式(I)で表され、ペルォキシダーゼの存在下に 過酸化水素の定量に用いられる呈色試薬を構成するのに特に好ましい本発明の尿 素誘導体の例として、下記の式 (III)または(IV)で表される化合物が挙げられるが、こ れらに限定されるものではない。 [0016] In the formula (Π) that represents R 1 of the formula (I) representing the urea derivative of the present invention, n is a force that is an integer of;! To 4, preferably 2. In the formula (Π), X represents a hydrogen atom, a sodium atom or a potassium atom, preferably a sodium atom. Further, R 2 and R 3 in formula (I) each independently represent a 4-disubstituted aminoaryl group, and the aryl groups of R 2 and R 3 are bonded to each other via a sulfur atom or an oxygen atom. Also good. Furthermore, this embodiment, which may be substituted with at least one S sulfonic acid group in the aryl group of R 2 and R 3 , includes the case where a sulfonic acid group is bonded to the substituted amino group. Here, a phenyl group is preferred as an aryl group. As an example of the urea derivative of the present invention particularly preferred for constituting a color reagent represented by the formula (I) and used for the determination of hydrogen peroxide in the presence of peroxidase, the following formula ( Examples thereof include, but are not limited to, compounds represented by III) or (IV).
[0017] [化 5]
Figure imgf000007_0001
[0017] [Chemical 5]
Figure imgf000007_0001
[0018] [化 6] [0018] [Chemical 6]
Figure imgf000007_0002
Figure imgf000007_0002
[0019] 式 (I)で表される本発明の尿素誘導体は、本発明者によって見出された合成法によ り合成すること力できる。すなわち、図 1に例示するように、式 (I)において R2が CH C OONaである化合物を原料とし(したがって、この原料化合物は式 (C 1)や式 (C 2)の化合物のように特許文献 2の対象とする化合物に相当する)、これに、ジシクロ へキシルカルポジイミドのようなカルポジイミドを脱水縮合剤として、タウリン(2—ァミノ エタンスルホン酸)のようなアミノアルカンスルホン酸を反応させる(後述の実施例参 昭) [0019] The urea derivative of the present invention represented by the formula (I) can be synthesized by the synthesis method found by the present inventors. That is, as illustrated in FIG. 1, a compound in which R 2 is CH C OONa in the formula (I) is used as a raw material (therefore, this raw material compound is a compound of the formula (C 1) or the formula (C 2). (This corresponds to the target compound of Patent Document 2), and this is reacted with an aminoalkanesulfonic acid such as taurine (2-aminoethanesulfonic acid) using a carpositimide such as dicyclohexylcarpositimide as a dehydrating condensing agent. (See examples below)
以下に本発明の特徴を更に具体的に示すために実施例を記す力 本発明はこれ らの実施例に限定されるものではない。  In order to show the features of the present invention more specifically, examples are described below. The present invention is not limited to these examples.
実施例 1  Example 1
[0020] Ν,Ν—ビス(4ージメチルァミノフエニル) N' (スルホェチル)ーァミノカルボニルメ チル尿素、 Na塩「本発明化合物 (111)〕の合成  [0020] Synthesis of Ν, Ν-bis (4-dimethylaminophenyl) N '(sulfoethyl) aminocarbonylmethylurea, Na salt “the present compound (111)”
図 1の (A)に示す反応式に従って、以下のように、式 (III)の本発明化合物を合成し た。式(C 1)の化合物 2.0gに 0.1N HCllOmlを入れ、濃縮した。濃縮物に THF20ml 、水 3ml及びジシクロへキシルカルポジイミド 3.27gを加え、氷浴下で撹拌した。 30分 撹拌後、タウリン 0.662g及び炭酸水素ナトリウム 0.444gを水 3mlに溶解し、反応液に加 えた。ー晚室温で撹拌後、さらにジシクロへキシルカルポジイミド 2.18g加えた。 3時間 後、撹拌を止め、反応液をろ過し、濃縮した。濃縮物に水 20mlを加えろ過後、ろ液を 濃縮し、淡青白色固体 2.61g得て、クロ口ホルム:メタノール =9 : 1〜7: 3でカラム精製 を行い、白色粉末 1.73g得た。クロ口ホルム 100mlで懸濁洗い後、ろ取し、ろ取物を減 圧乾燥後、白色粉末 1.66g得た。 According to the reaction formula shown in (A) of FIG. 1, the compound of the present invention of the formula (III) was synthesized as follows. To 2.0 g of the compound of formula (C 1) was added 0.1N HCllOml and concentrated. 20ml THF to concentrate 3 ml of water and 3.27 g of dicyclohexyl carpositimide were added and stirred in an ice bath. After stirring for 30 minutes, 0.662 g of taurine and 0.444 g of sodium bicarbonate were dissolved in 3 ml of water and added to the reaction solution. -After stirring at room temperature, 2.18 g of dicyclohexyl carpositimide was further added. After 3 hours, stirring was stopped and the reaction solution was filtered and concentrated. After adding 20 ml of water to the concentrate and filtering, the filtrate was concentrated to obtain 2.61 g of a pale blue-white solid, which was subjected to column purification with chloroform: methanol = 9: 1-7: 3 to obtain 1.73 g of a white powder. The suspension was washed with 100 ml of black mouth form, filtered, and the filtered material was dried under reduced pressure to obtain 1.66 g of a white powder.
〔同定データ〕 [Identification data]
TLC (シリカゲル、ブタノール:酢酸:ピリジン:水 =4: 1: 1: 2): Rf=0.45。  TLC (silica gel, butanol: acetic acid: pyridine: water = 4: 1: 1: 2): Rf = 0.45.
NMR (D 0): δ ppm 2·82(12Η, NMR (D 0): δ ppm 2 · 82 (12Η,
s, -N-(CH ) )、 3.08ppm(2H, d,— CH— CH—SO Na)、 3.61ppm(2H, d,— CH— CH—SOs, -N- (CH)), 3.08 ppm (2H, d, — CH—CH—SO Na), 3.61 ppm (2H, d, — CH— CH—SO
Na)、 3.76ppm(2H, s, - NH_CH -CO -)、 6.92— 7.27ppm(8H, m, aromatic H)。 Na), 3.76 ppm (2H, s, -NH_CH -CO-), 6.92-7.27 ppm (8H, m, aromatic H).
MS : [M-Na] = 462。 MS: [M-Na] = 462.
実施例 2 Example 2
10-「(スルホェチノレ) ァミノカルボ二ルメチルー(ァミノカルボニル) 1 -3.7-ビス (ジメ チルァミノ)フエノチアジン、 Na塩「本発明化合物 (1 〕の合成  10-"(sulfoechinole) aminocarbonylmethyl- (aminocarbonyl) 1 -3.7-bis (dimethylamino) phenothiazine, Na salt" Synthesis of Compound (1) of the Present Invention
図 1の(B)に示す反応式に従って、以下のように、式 (IV)の本発明化合物を合成し た。式(C 2)の化合物 l.Ogに 0.1N HCllOmlを入れ、濃縮した。濃縮物に THFlOml 、水 3ml及びジシクロへキシルカルポジイミド 2.16gを加え、氷浴下で撹拌した。 30分 撹拌後、タウリン 0.328g及び炭酸水素ナトリウム 0.213gを水 3mlに溶解し、反応液に加 えた。 3時間後、撹拌を止め、反応液をろ過し、濃縮した。濃縮物をクロ口ホルムで力 ラム精製を行い、減圧乾燥後、白色粉末 0.40g得た。  According to the reaction formula shown in FIG. 1 (B), the compound of the present invention of the formula (IV) was synthesized as follows. The compound l.Og of the formula (C2) was charged with 0.1N HCllOml and concentrated. To the concentrate were added THFlOml, 3 ml of water and 2.16 g of dicyclohexyl carpositimide, and the mixture was stirred in an ice bath. After stirring for 30 minutes, 0.328 g of taurine and 0.213 g of sodium bicarbonate were dissolved in 3 ml of water and added to the reaction solution. After 3 hours, stirring was stopped and the reaction solution was filtered and concentrated. The concentrate was purified by chromoform form and dried under reduced pressure to obtain 0.40 g of white powder.
〔同定データ〕 [Identification data]
TLC (シリカゲル、クロ口ホルム:メタノール = 9 : 1): Rf=0.15。  TLC (silica gel, black mouth form: methanol = 9: 1): Rf = 0.15.
NMR(D Ο) : δ ppm 2·82(12Η, s, - N_(CH ) )、 3.12ppm(2H, d, - CH - CH—SO Na)、 3. 70ppm(2H, d,— CH -CH^SO^a), 3.80ppm(2H, s,— NH— CF^— CO―)、 6.50— 7.41ppm( 6H, m, aromatic H)。  NMR (D Ο): δ ppm 2 · 82 (12 Η, s,-N_ (CH)), 3.12 ppm (2H, d,-CH-CH-SO Na), 3. 70 ppm (2H, d,-CH- CH ^ SO ^ a), 3.80 ppm (2H, s, —NH—CF ^ —CO—), 6.50—7.41 ppm (6H, m, aromatic H).
MS : [M-Na]—=492。 実施例 3 MS: [M-Na] — = 492. Example 3
[0022] 渦酸化水素の定量 [0022] Determination of vortex hydrogen oxide
〔測定溶液〕  (Measurement solution)
本発明化合物 (III)および (IV)、ならびに比較のために特許文献 2に記載の化合物( C 1 )および(C 2)のそれぞれを 0· lmmol/Uペルォキシダーゼを 3.3u/mlの濃度 になるように、 50mM MES〔2 モルホリノエタンスルホン酸〕 水酸化ナトリウム緩衝液 (pH5.5)に溶解した。  The compounds (III) and (IV) of the present invention and the compounds (C 1) and (C 2) described in Patent Document 2 for comparison have a concentration of 0 · lmmol / U peroxidase at a concentration of 3.3 u / ml. Thus, it was dissolved in 50 mM MES [2 morpholinoethanesulfonic acid] sodium hydroxide buffer (pH 5.5).
〔試料液〕  [Sample solution]
市販過酸化水素水を純水で lmmol/1の濃度になるように希釈した。  Commercially available hydrogen peroxide was diluted with pure water to a concentration of 1 mmol / 1.
〔測定方法〕  〔Measuring method〕
測定溶液 3mlに試料液を 1.5、 3.0、 15及び 30 1加え、 37°Cで 5分間加温後、極大吸 収波長における吸光度を測定した。  The sample solution was added to 3 ml of the measurement solution 1.5, 3.0, 15 and 301 and heated at 37 ° C for 5 minutes, and then the absorbance at the maximum absorption wavelength was measured.
〔結果〕  [Result]
図 2Aおよび図 2Bに過酸化水素濃度と吸光度との関係を示す。図 2Aおよび図 2B より、各過酸化水素濃度 M)に対してプロットした極大吸収波長における吸光度の 検量線は定量性を示した。本発明化合物 (III)および (IV)は比較化合物(C 1)およ び (C 2)と同等以上の感度を示した。  Figures 2A and 2B show the relationship between hydrogen peroxide concentration and absorbance. From FIG. 2A and FIG. 2B, the calibration curve of absorbance at the maximum absorption wavelength plotted against each hydrogen peroxide concentration M) showed quantitativeness. The compounds (III) and (IV) of the present invention showed the same or better sensitivity than the comparative compounds (C 1) and (C 2).
実施例 4  Example 4
[0023] 7kに すろ [0023] 7k
本発明化合物 (III)および (IV)ならびに比較化合物(C 1)および (C 2)のそれぞ れを 25°Cの純水に溶解し、溶解度を求めた。表 1に本発明化合物 (III)および (IV)、比 較化合物(C 1 )および (C 2)の溶解度を示す。  The compounds (III) and (IV) of the present invention and the comparative compounds (C 1) and (C 2) were each dissolved in pure water at 25 ° C., and the solubility was determined. Table 1 shows the solubilities of the compounds (III) and (IV) of the present invention and the comparative compounds (C 1) and (C 2).
[0024] [表 1] 水に対する溶解度 [0024] [Table 1] Solubility in water
Figure imgf000010_0001
Figure imgf000010_0001
[0025] 表 1に示されるように、本発明化合物 (III)および (IV)は、(C 1)および(C 2)よりも それぞれ水溶性が大きい。 [0025] As shown in Table 1, the compounds (III) and (IV) of the present invention are more water-soluble than (C 1) and (C 2), respectively.
実施例 5  Example 5
[0026] 溶液安定性 [0026] Solution stability
〔保存溶液〕  [Preservation solution]
本発明化合物 (III)および (IV)、比較化合物(C 1)および (C 2)のそれぞれにつ いて 10mmol/lとなるように、 50mM MES 水酸化ナトリウム緩衝液(ρΗ5·5)で調製し、 遮光、 40°Cで保存した。  The compounds (III) and (IV) of the present invention and the comparative compounds (C 1) and (C 2) were each prepared with 50 mM MES sodium hydroxide buffer (ρΗ5 · 5) so as to be 10 mmol / l. Stored at 40 ° C, protected from light.
〔試料液〕  [Sample solution]
市販過酸化水素水を純水で lmmol/1の濃度になるように希釈した。  Commercially available hydrogen peroxide was diluted with pure water to a concentration of 1 mmol / 1.
〔測定方法〕  〔Measuring method〕
保存溶液 30 1に 50mM MES 水酸化ナトリウム緩衝液(ρΗ5·5) 2.9ml、ペルォキシ ダーゼ水溶液(33011/½1) 30 1及び試料液を 30 1加え、 37°Cで 5分間加温後、極大 吸収波長における吸光度を測定した。  Add 2.9 ml of 50 mM MES sodium hydroxide buffer (ρΗ5 · 5), peroxidase aqueous solution (33011 / ½1) 30 1 and 30 1 to the stock solution 30 1, heat at 37 ° C for 5 minutes, and then absorb maximum. Absorbance at wavelength was measured.
〔結果〕  [Result]
図 3Aおよび図 3Bに経過日と吸光度との関係を示す。図 3Aおよび図 3Bに示され るように、本発明化合物 (III)および (IV)は、比較化合物(C 1)および (C 2)よりも 良好な安定性を有している。  Figures 3A and 3B show the relationship between elapsed days and absorbance. As shown in FIGS. 3A and 3B, the compounds (III) and (IV) of the present invention have better stability than the comparative compounds (C 1) and (C 2).

Claims

請求の範囲  The scope of the claims
下記の一般式 (I)で表されることを特徴とする尿素誘導体。  A urea derivative represented by the following general formula (I):
Figure imgf000011_0001
Figure imgf000011_0001
〔式 (I)中、 R1は下記の一般式 (Π)で表される原子団を示し、 ITおよび R3は、それぞ れ独立して、 4ージ置換アミノアリール基を表わし、 R2と R3のァリール基は硫黄原子ま たは酸素原子を介して互いに結合してもよぐさらに、 R2と R3のァリール基の少なくと も 1ケ所カ Sスルホン酸基で置換されていてもよい。〕 [In formula (I), R 1 represents an atomic group represented by the following general formula (Π), IT and R 3 each independently represents a 4-disubstituted aminoaryl group, R The aryl groups of 2 and R 3 may be bonded to each other via a sulfur atom or an oxygen atom, and at least one of the aryl groups of R 2 and R 3 is substituted with an S sulfonic acid group. May be. ]
[化 2] [Chemical 2]
Yes
II H 、  II H,
~ C H2- C - N -(C H2)N- S 03X UIJ ~ CH 2 -C-N-(CH 2 ) N -S 0 3 X UIJ
〔式 (Π)中、 nは 1〜4の整数を表し、 Xは水素原子、ナトリウム原子またはカリウム原 子を表す。〕 [In the formula (Π), n represents an integer of 1 to 4, and X represents a hydrogen atom, a sodium atom or a potassium atom. ]
下記の式 (III)または式 (IV)で表されることを特徴とする請求項 1の尿素誘導体。  The urea derivative according to claim 1, which is represented by the following formula (III) or formula (IV):
[化 3] [Chemical 3]
Figure imgf000011_0002
Figure imgf000011_0002
[化 4] [Chemical 4]
Figure imgf000012_0001
Figure imgf000012_0001
[3] 請求項 1または 2に記載のいずれかの尿素誘導体から成り、ペルォキシダーゼの存 在下に過酸化水素の定量に用いられることを特徴とする呈色試薬。 [3] A color reagent comprising the urea derivative according to any one of claims 1 and 2, which is used for the determination of hydrogen peroxide in the presence of peroxidase.
PCT/JP2007/069799 2006-10-16 2007-10-11 Urea derivative for use in quantification of hydrogen peroxide WO2008047655A1 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
JP2006-280844 2006-10-16
JP2006280844A JP2010001217A (en) 2006-10-16 2006-10-16 Urea derivative for use in quantitative measurement of hydrogen peroxide

Publications (1)

Publication Number Publication Date
WO2008047655A1 true WO2008047655A1 (en) 2008-04-24

Family

ID=39313893

Family Applications (1)

Application Number Title Priority Date Filing Date
PCT/JP2007/069799 WO2008047655A1 (en) 2006-10-16 2007-10-11 Urea derivative for use in quantification of hydrogen peroxide

Country Status (2)

Country Link
JP (1) JP2010001217A (en)
WO (1) WO2008047655A1 (en)

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2018159636A1 (en) * 2017-02-28 2018-09-07 株式会社同仁化学研究所 Novel oxidation color developable compound and oxidation color development reagent

Citations (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS63246356A (en) * 1986-07-01 1988-10-13 Wako Pure Chem Ind Ltd Novel urea derivative and method for measurement using said derivative as coloring component
JPH01128797A (en) * 1987-11-13 1989-05-22 Kyowa Medetsukusu Kk Method for quantitative determination of compound
JPH06289015A (en) * 1993-03-30 1994-10-18 Sunstar Inc Stabilized phenothiazine chromogen composition

Patent Citations (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS63246356A (en) * 1986-07-01 1988-10-13 Wako Pure Chem Ind Ltd Novel urea derivative and method for measurement using said derivative as coloring component
JPH01128797A (en) * 1987-11-13 1989-05-22 Kyowa Medetsukusu Kk Method for quantitative determination of compound
JPH06289015A (en) * 1993-03-30 1994-10-18 Sunstar Inc Stabilized phenothiazine chromogen composition

Cited By (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2018159636A1 (en) * 2017-02-28 2018-09-07 株式会社同仁化学研究所 Novel oxidation color developable compound and oxidation color development reagent
US20190270888A1 (en) * 2017-02-28 2019-09-05 Dojindo Laboratories Novel oxidation color developable compound and oxidation color development reagent
US10787571B2 (en) 2017-02-28 2020-09-29 Dojindo Laboratories Oxidation color developable compound and oxidation color development reagent

Also Published As

Publication number Publication date
JP2010001217A (en) 2010-01-07

Similar Documents

Publication Publication Date Title
CN109232626B (en) SO based on difluoro boro coumarin2Ratiometric fluorescent probes
WO2007055364A1 (en) Fluorescent probe for peroxynitrite
CN109336835B (en) Fluorescent probe for detecting activity of myeloperoxidase and preparation method and application thereof
CN113461609B (en) Sulfatase-responsive AIE nano probe and preparation method and application thereof
CN109851546A (en) A kind of acid pH probe compound and preparation method thereof
CN114605343B (en) Fluorescent group LAN-OH, fluorescent sensor LAN-beta gal, preparation method and application thereof
CN110563708B (en) Turn-on type fluorescent probe for rapidly detecting sulfite (hydrogen) salt, and synthesis method and application thereof
CN111892552A (en) Triphenylamine derivative, preparation method thereof and application thereof in double-channel fluorescence detection of hydrogen sulfide
WO2008047655A1 (en) Urea derivative for use in quantification of hydrogen peroxide
JPH0655158B2 (en) Fluorogenic substrate
JPWO2003057905A1 (en) Colorimetric analysis method and reagent used therefor
JPH04202164A (en) Oxidizable color reagent
CN113683658B (en) Method for modifying protein histidine residue
CN110105280B (en) Water-soluble fluorescent probe based on 1, 8-naphthalimide and preparation method and application thereof
JP4614885B2 (en) Water-soluble tetrazolium compound
JP5231063B2 (en) Method for producing oxidation coloring compound
CN110357869B (en) HClO fluorescent probe designed based on ICT mechanism, and synthetic method and application thereof
JP2995380B2 (en) New water-soluble tetrazolium salt compound
JP5329867B2 (en) Method for producing oxidation coloring compound
CN115340581B (en) Synthesis method and application of o-phenol sulfenamide on-DNA compound
CN114644623B (en) Thiophene aldehyde coupled quinoline salt NIR-LS3 and synthesis method and application thereof
CN117088812A (en) Two-photon fluorescent probe for detecting industrial hydrogen sulfide or sodium sulfide and preparation method thereof
JPH0770462A (en) Water-soluble methylenebisdialkylaniline derivative, salts thereof and composition for determining peroxide substance using the same derivative and sails
JP2819258B2 (en) New water-soluble tetrazolium salt compound
JP2015048345A (en) Oxidation coloring compound and application thereof

Legal Events

Date Code Title Description
121 Ep: the epo has been informed by wipo that ep was designated in this application

Ref document number: 07829537

Country of ref document: EP

Kind code of ref document: A1

NENP Non-entry into the national phase

Ref country code: DE

122 Ep: pct application non-entry in european phase

Ref document number: 07829537

Country of ref document: EP

Kind code of ref document: A1

NENP Non-entry into the national phase

Ref country code: JP